TradeFlare's AI research teams analysed LQDA on 11 market nights between April 23, 2026 and August 13, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.
| Date | Verdict | Price | Target / stop | 5 days later | 20 days later | Why (that night) |
|---|---|---|---|---|---|---|
| August 13, 2026 | BUY | $78.79 | $90.61 / $66.97 | -1.5% | -7.4% | The scanner trigger suggests a short-term mean-reversion opportunity, while the fundamental strength supports a longer-term outlook. |
| July 14, 2026 | BUY | $71.21 | — / — | +5.8% | +15.1% | Continued positive performance and market adoption of Yutrepia. |
| June 12, 2026 | BUY | $71.62 | $88.00 / $60.88 | +6.0% | +7.4% | The post-earnings drift pattern suggests momentum could persist for several weeks. |
| June 10, 2026 | BUY | $64.01 | $77.00 / $54.41 | +5.2% | +19.4% | The post-earnings drift suggests continued upward momentum over the coming weeks. |
| June 9, 2026 | BUY | $63.90 | — / — | +6.2% | +27.2% | The scanner trigger suggests a short-term post-earnings drift, but the fundamental and risk profiles warrant caution. |
| May 19, 2026 | BUY | $56.93 | $65.50 / $48.39 | +3.4% | +14.4% | The post-earnings drift signal suggests continued upward momentum over a few weeks. |
| May 18, 2026 | BUY | $56.93 | $65.50 / $48.39 | +5.5% | +19.4% | The post-earnings drift signal suggests continued upward momentum over a few weeks. |
| May 15, 2026 | BUY | $59.30 | $74.13 / $50.41 | +7.1% | +26.1% | The post-earnings drift (PEAD) signal suggests continued upward momentum following a strong earnings beat. |
| May 12, 2026 | BUY | $53.13 | $66.41 / $45.16 | +6.0% | +15.3% | The post-earnings drift signal suggests continued upward momentum over the medium term. |
| April 24, 2026 | SELL | $37.46 | — / — | +2.2% | +63.4% | Continued strong YUTREPIA sales performance. |
| April 23, 2026 | SELL | $37.06 | — / — | +4.7% | +65.4% | Resolution of ongoing patent litigation with United Therapeutics. |
Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.